Suppr超能文献

T细胞对柯萨奇病毒B4致糖尿病株P2C非结构蛋白的反应性。

T-Cell reactivity to the P2C nonstructural protein of a diabetogenic strain of coxsackievirus B4.

作者信息

Varela-Calvino R, Sgarbi G, Arif S, Peakman M

机构信息

Department of Immunology, Guy's, King's, and St. Thomas' School of Medicine, Rayne Institute, 123 Coldharbour Lane, London SE5 9NU, United Kingdom.

出版信息

Virology. 2000 Aug 15;274(1):56-64. doi: 10.1006/viro.2000.0446.

Abstract

Enteroviruses are proposed as initiating factors in the etiology of Type 1 diabetes mellitus (Type 1 DM). Molecular mimicry between the autoantigen glutamic acid decarboxylase 65 (GAD65) and the coxsackievirus B4 (CVB4) nonstructural protein P2C is frequently cited as a mechanism by which this virus triggers the disease, but little is known about the immunogenicity of this viral protein in humans, mainly due to the problem of obtaining highly pure preparations of P2C. We generated large amounts of highly pure, soluble P2C protein, coupled to the fusion partner maltose binding protein (MBP-P2C) using the PMAL-c2 bacterial expression plasmid and a two-step purification system comprising amylose resin and ion exchange. Using purified viral protein we show that specific T-cell responses against P2C are detected in the blood of healthy donors and Type 1 DM patients. Proliferation responses to P2C were detected only in subjects also demonstrating T-cell proliferation to CVB4 Vero cell lysates. However, in additional cases T-cell responses to P2C were detectable through the release of interferon-gamma or interleukin-4 in individuals who did not make proliferative responses. Taken together, our data show that the P2C nonstructural protein of CVB4 is targeted by T cells during the antiviral immune response and may trigger the production of T helper 1 and T helper 2 cytokines. The availability of pure, immunogenic P2C should allow the putative role of antiviral responses in the development of autoimmune diabetes to be investigated.

摘要

肠道病毒被认为是1型糖尿病(T1DM)病因中的起始因素。自身抗原谷氨酸脱羧酶65(GAD65)与柯萨奇病毒B4(CVB4)非结构蛋白P2C之间的分子模拟常被引为该病毒引发疾病的一种机制,但对于这种病毒蛋白在人类中的免疫原性知之甚少,主要是因为难以获得高度纯化的P2C制剂。我们使用PMAL-c2细菌表达质粒和包含直链淀粉树脂及离子交换的两步纯化系统,生成了大量与融合伴侣麦芽糖结合蛋白(MBP-P2C)偶联的高度纯化的可溶性P2C蛋白。利用纯化的病毒蛋白,我们发现健康供体和1型糖尿病患者的血液中可检测到针对P2C的特异性T细胞反应。仅在那些对CVB4 Vero细胞裂解物也表现出T细胞增殖的受试者中检测到了对P2C的增殖反应。然而,在其他情况下,在未产生增殖反应的个体中,通过干扰素-γ或白细胞介素-4的释放可检测到对P2C的T细胞反应。综上所述,我们的数据表明,在抗病毒免疫反应期间,CVB4的P2C非结构蛋白是T细胞的靶标,并且可能触发辅助性T细胞1和辅助性T细胞2细胞因子的产生。纯的、具有免疫原性的P2C的可得性应有助于研究抗病毒反应在自身免疫性糖尿病发展中的假定作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验